Rocket Pharmaceuticals Balance Sheet (2014-2026) | RCKT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Accumulated Depreciation (Quarter)	3.43M	4.23M	5.22M	5.99M	6.95M	8.00M	9.09M	10.23M	11.42M	12.64M	14.03M	15.75M	17.58M	19.43M	21.25M	23.70M	25.74M	27.45M	29.12M	30.73M
Assets
Current Assets
Cash & Equivalents (Quarter)	264.61M	421.50M	232.69M	346.60M	321.40M	306.50M	140.52M	360.00M	45.08M	437.20M	55.90M	35.28M	278.80M	65.60M	163.63M	49.81M	32.82M	222.80M	77.56M	144.40M
Prepaid Assets (Quarter)	3.60M	3.61M	3.32M	7.25M	4.40M	4.60M	7.67M	6.95M	5.03M	9.69M	5.05M	14.85M	13.90M	6.09M	5.85M	6.33M	5.66M	4.92M	3.81M	5.45M
Current Assets (Quarter)	430.43M	425.07M	392.06M	353.85M	325.77M	311.13M	364.06M	338.03M	312.07M	446.87M	378.22M	345.16M	292.73M	241.75M	378.18M	324.49M	277.15M	227.68M	192.73M	149.83M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	20.99M	22.09M	22.30M	24.35M	24.85M	25.61M	29.01M	30.59M	32.99M	36.53M	39.17M	39.34M	39.55M	38.51M	36.79M	34.56M	32.52M	29.77M	28.17M	26.66M
Long-Term Investments (Quarter)							43.28M	28.96M			34.32M
Goodwill (Quarter)	30.82M	30.82M	30.82M	30.82M	30.82M	30.82M	39.20M	39.15M	39.15M	39.15M	39.20M	39.15M	39.20M	39.15M	39.20M	39.20M	39.20M	39.20M	39.20M	39.15M
Intangibles (Quarter)							25.72M	25.72M	25.72M	25.15M	25.15M	25.15M	25.15M	25.15M	25.15M	25.15M	25.15M	25.15M	25.15M	25.15M
Goodwill & Intangibles (Quarter)	30.82M	30.82M	30.82M	30.82M	30.82M	30.82M	64.92M	64.88M	64.88M	64.30M	64.35M	64.30M	64.35M	64.30M	64.35M	64.35M	64.35M	64.35M	64.35M	64.30M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	0.46M	1.33M	1.34M	0.46M	1.34M	1.35M	1.34M	1.34M	0.54M	0.54M	0.53M	1.36M	0.48M	1.36M	0.53M	1.36M	1.36M	1.36M	0.48M	1.34M
Non-Current Assets (Quarter)	-429.03M	-423.94M	-391.33M	-352.21M	-325.37M	-309.38M	187.75M	-336.24M	-310.81M	-445.19M	188.12M	154.28M	153.69M	151.93M	149.52M	146.57M	143.82M	140.35M	137.72M	135.58M
Assets (Quarter)	1.39M	1.13M	0.73M	1.64M	0.41M	1.75M	551.81M	1.79M	1.26M	1.67M	566.34M	499.44M	446.41M	393.69M	527.70M	471.07M	420.98M	368.03M	330.45M	285.41M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	17.88M	22.01M	19.61M	20.03M	21.84M	27.82M	36.66M	28.61M	31.35M	30.62M	45.79M	30.09M	34.73M	37.13M	37.83M	32.44M	40.51M	28.26M	27.29M	21.54M
Notes Payables (Quarter)	5.10M
Payables (Quarter)	22.99M	22.01M	19.61M	20.03M	21.84M	27.82M	36.66M	28.61M	31.35M	30.62M	45.79M	30.09M	34.73M	37.13M	37.83M	32.44M	40.51M	28.26M	27.29M	21.54M
Accumulated Expenses (Quarter)	1.27M		4.53M	1.64M	0.41M	4.79M	10.01M	1.79M	6.01M	8.36M	9.93M	4.19M	7.29M	10.32M	11.94M	7.07M	8.05M	11.43M	12.29M	5.24M
Other Accumulated Expenses (Quarter)	0.67M	0.65M	0.48M	0.96M	0.65M	1.88M	2.27M	1.67M	1.11M	1.85M	1.77M	2.75M	3.06M	2.77M	1.62M	2.94M	1.71M	2.67M	2.33M	4.22M
Current Leases (Quarter)	1.67M	0.80M	1.69M	0.84M	1.71M	0.63M	1.74M	0.85M	1.23M	1.77M	1.79M	1.06M	1.03M	1.00M	1.00M	1.01M	1.88M	1.90M	1.00M	1.93M
Total Current Liabilities (Quarter)	25.44M	24.49M	22.17M	22.57M	24.29M	30.18M	39.17M	31.21M	34.35M	33.48M	48.51M	32.96M	37.59M	39.98M	40.68M	35.31M	43.40M	31.17M	30.21M	24.47M
Non-Current Liabilities
Capital Leases (Quarter)	19.07M	19.11M	19.14M	19.18M	19.21M	19.24M	19.27M	19.29M	19.32M	19.34M	19.35M	19.36M	19.37M	19.38M	19.38M	19.38M	19.38M	19.38M	19.36M	19.35M
Non-Current Debt (Quarter)
Convertible Debt (Quarter)
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)	1.10M	0.89M	0.91M	0.72M	0.61M	0.49M	1.09M	0.20M	3.07M	2.99M	2.97M	3.71M	3.56M	3.41M	3.26M	3.10M	2.93M	2.76M	2.60M	2.49M
Other Non-Current Liabilities (Quarter)	0.11M	0.09M	0.08M	0.07M	0.05M	0.04M	2.60M	1.88M	2.07M	1.87M	2.94M	1.91M	1.25M	1.14M	1.14M	1.14M	1.06M	1.06M	1.06M	1.06M
Total Non-Current Liabilities (Quarter)	45.61M	44.49M	42.22M	42.47M	44.10M	49.91M	59.53M	54.01M	56.74M	55.81M	70.83M	56.03M	60.53M	62.77M	63.33M	57.79M	65.71M	53.30M	52.17M	46.31M
Total Liabilities (Quarter)	45.72M	44.58M	42.30M	42.53M	44.16M	49.95M	62.12M	55.88M	58.81M	57.68M	73.77M	57.94M	61.78M	63.92M	64.47M	58.93M	66.77M	54.36M	53.23M	47.37M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	489.44M	485.66M	454.72M	417.62M	387.70M	367.31M	489.69M	458.88M	402.97M	541.09M	492.57M	441.50M	384.63M	329.77M	463.23M	412.14M	354.21M	313.67M	277.22M	238.04M
Liabilities and Shareholders Equity (Quarter)	1.39M	1.13M	0.73M	1.64M	0.41M	1.75M	551.81M	1.79M	1.26M	1.67M	566.34M	499.44M	446.41M	393.69M	527.70M	471.07M	420.98M	368.03M	330.45M	285.41M
Treasury Shares (Quarter)	0.02M	0.02M	1.22M	0.46M	1.22M	1.22M	2.72M	2.60M	1.65M	5.72M		5.72M	1.68M	1.57M	1.41M	4.05M	4.38M	5.50M	5.00M	7.70M
Retained Earnings (Quarter)	-397.55M	-447.70M	-491.91M	-0.63M	-589.30M	-0.60M	-713.77M	-0.09M	-0.72M	1,440.40M	1,450.72M	1,462.15M	-0.22M	-1157.79M	0.07M	1,690.55M	-0.11M	-0.01M	-0.03M	-0.11M
Preferred Shares (Quarter)

Research Tools

Developers

Rocket Pharmaceuticals Balance Sheet (2014-2026) | RCKT

Research Tools

Developers

Rocket Pharmaceuticals Balance Sheet (2014-2026) | RCKT

Create an account

Sign In

Reset Password